Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.

Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.

http://www.wikidata.org/entity/Q35006827

about

Infection of Brindley sacral anterior root stimulator by Pseudomonas aeruginosa requiring removal of the implant: long-term deleterious effects on bowel and urinary bladder function in a spinal cord injury patient with tetraplegia: a case report Complications of cardiac implants: handling device infections Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement New horizon for infection prevention technology and implantable device Combination prophylactic therapy with rifampin increases efficacy against an experimental Staphylococcus epidermidis subcutaneous implant-related infection Mortality in patients on renal replacement therapy and permanent cardiac pacemakers.HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011 Antibiotics and antiseptics to prevent infection in cardiac rhythm management device implantation surgery.Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.Novel approaches to the diagnosis, prevention, and treatment of medical device-associated infections Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice Cardiac Implantable Electronic Device Infection in Patients at Risk.Lead extractions in patients with cardiac implantable electronic device infections: Single center experience.Critical appraisal of cardiac implantable electronic devices: complications and management Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects Management of Cardiac Implantable Electronic Device Infection Cardiac pacing and defibrillation in children and young adults.How Long Should Prophylactic Antibiotics be Prescribed for Permanent Pacemaker Implantations? One Day versus Three Days Management of Cardiac Electronic Device Infections: Challenges and Outcomes.Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.Microbiological Characteristics and Clinical Features of Cardiac Implantable Electronic Device Infections at a Tertiary Hospital in China.Contemporary management of cardiovascular implantable electronic device infections.From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems.Candida endocarditis associated with cardiac rhythm management devices: review with current treatment guidelines.Spinal cord stimulation: a review.Infective endocarditis prophylaxis: moving from dental prophylaxis to global prevention?A review of epidural catheter-related infections.An evaluation of hardware and surgical complications with deep brain stimulation based on diagnosis and lead location.The prevalence of methicillin resistant organisms among pacemaker and defibrillator implant recipients.Current trends in the management of cardiac implantable electronic device (CIED) infections.2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.A simple infection-control protocol to reduce serious cardiac device infections.Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British He Infected cardiac-implantable electronic devices: prevention, diagnosis, and treatment.Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.Pocket Hematoma: A Call for Definition.Managing anticoagulation in patients receiving implantable cardiac devices.Long-Term Evaluation of Changes in Operative Technique and Hardware-Related Complications With Deep Brain Stimulation.International survey of knowledge, attitudes, and practices of cardiologists regarding prevention and management of cardiac implantable electronic device infections.

P2860

Q21198798-B5CF65B5-E019-4E01-A701-6F8D6A61CF0A Q26865664-202A06CA-6078-478C-8A57-28C142B7FF23 Q28073254-76C7F4AE-0859-4711-9E53-444A93C81249 Q28080257-0BC30E53-4635-4346-ADE8-819A0AC39D9D Q33622963-D11BEC84-D07A-4AC5-B977-585232387F30 Q33757747-0FCAB57F-B11E-4C58-86D7-F2768B578376 Q33815633-6E9403B3-B63D-44CF-9EED-FC498E7978D9 Q34402514-1C7E34A7-CA16-4AB8-98E0-59F12CDEF290 Q34793209-E890DA9A-B0EB-4CFF-9D61-D761F077CF61 Q35714452-4C2A2CFB-1BE4-4181-9B23-6D96AB00DC1C Q35941476-78D9E9B7-9F56-42D2-B165-E6C312196020 Q36073616-CBB69761-D941-4A1D-9328-7344E2F709A7 Q36121255-D9DB91DC-87DD-4410-8D76-2ECA45911AD6 Q36160503-FE47ECE5-12C5-440B-BD72-7EEC545DF6C6 Q36167225-0394B3A9-FF24-4FB2-B2EB-9B29225252D9 Q36458826-FC08D022-93C1-4B6B-958E-12AB3115B945 Q36515909-3FE52CEA-B6BB-49A3-B832-8EC127E40856 Q36721535-DBF71C14-948A-4BD2-92C0-0DEC6925F2F3 Q37596061-3472C716-195E-4045-8E10-53BFDE0496F7 Q37627394-6E457817-BE0B-437C-9CF3-96B39230DB3A Q37630347-57085CDA-D8C3-4A1C-8D9D-3297F4C49E72 Q37681139-3197F64C-621D-47AE-9671-0BEBACE2D9D7 Q37768419-DE930389-49E0-49AA-A89E-A7E4618BDB2E Q37850450-E2C1BA55-B145-4836-A780-0F88BC465FCA Q37889380-F3867C11-AA60-44F9-BB44-AD55D86A89C4 Q37956557-8529B6CC-770E-4B7C-AAF1-A61B87572C32 Q37987055-BB30B30B-970E-46F5-8ED4-3E126BBEC8DC Q38012083-B021B250-98F7-4093-9319-99593617F592 Q38017114-1F0D5BD6-8BD5-44E1-8E96-332446502AE4 Q38020489-A5A7D2FE-A809-4C46-B3B9-88B7E218284D Q38022551-9454E270-1606-4CB9-AE18-37DA1A09D6E0 Q38038846-9EA7F87D-3949-49F9-8229-BCCA5E2A8436 Q38219559-1EF8F5E6-E7C9-438C-8E1F-ADF2A6F2EF11 Q38263821-EFDCF3FE-E7C3-4FBE-A2E5-206F926A8995 Q38370148-78C9FF5D-04A2-46ED-AD45-CBB01BA5F87C Q38450566-68958E59-4F78-4891-B75C-31D11041700B Q38479890-6467C90A-9845-4BAE-BCC2-90D5DE18C22E Q38552586-15734348-BCD3-4EA4-9B2F-077EB02D9F97 Q38561345-ED6976B0-CDD0-4F37-BC2A-53F6C5FA379F Q38605893-C953FF20-4071-4597-96E3-85605D7138AD

P2860

Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.

http://www.wikidata.org/entity/Q35006827

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@ast

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@en

type

label

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@ast

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@en

prefLabel

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@ast

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@en

P1433

Q35006827-A9AE012B-298B-402F-915C-26D4D8886EEC

P1476

Q35006827-A64263CD-2835-41B5-96B3-13D15406C7C4

P2093

Q35006827-244F84D4-C5BB-46C5-AC04-B95CED54302B

Q35006827-64E92ECB-9A5E-4709-BD25-A47067F9A760

Q35006827-830A3797-22BA-4F9F-B271-0DA122C5985F

Q35006827-8725C07E-C37B-4929-A7C6-A73AED361BAA

Q35006827-903DC1B5-95F0-4C8C-8585-71B2BB7D8FC2

Q35006827-AAF17B56-B0DE-4DE3-ADE7-6BCEF92A6596

Q35006827-B40ABF38-E8E0-401B-90F1-A12987681420

Q35006827-E5518B28-EDBC-4C22-90DC-1C219F303F41

P304

Q35006827-091CA795-291D-4B33-95EF-C090707D33AA

P31

Q35006827-E12BFF99-F7F0-4C41-AF93-DAABED90C884

P356

Q35006827-AADC47F4-E065-443D-8BD1-A2E0A791C11E

P433

Q35006827-BD6A79B1-48E4-496C-A394-3B2D7022B93A

P478

Q35006827-AE30957B-5C55-4BC6-B5D4-398AFF9192B4

P50

Q35006827-324B5E2D-8DBB-4509-8E47-E9B5DDA4DDCD

P577

Q35006827-B8AE60AC-23DA-4937-9868-B13F47033636

P698

Q35006827-5C49E04B-40A4-4301-A38A-B0B0961E0026

P921

Q35006827-60DE37DF-032E-4C6B-BC7D-8190B848DA08

Q35006827-78DCD960-0962-4D5A-93A4-C590C8FC9EBE

Q35006827-E4B5B255-3EC3-4E6A-A158-4D8C8E719BCD

P356

CIRCEP.108.795906

P1433

Circulation: Arrhythmia and Electrophysiology

P1476

Efficacy of antibiotic prophyl ...... ded, placebo-controlled trial.

@en

P2093

Andre D'Avila

http://www.w3.org/2001/XMLSchema#string

Anísio Alexandre Andrade Pedrosa

http://www.w3.org/2001/XMLSchema#string

David Uipe

http://www.w3.org/2001/XMLSchema#string

Julio Cesar de Oliveira

http://www.w3.org/2001/XMLSchema#string

Martino Martinelli

http://www.w3.org/2001/XMLSchema#string

Silvana Angelina D'Orio Nishioka

http://www.w3.org/2001/XMLSchema#string

Stephan B Danik

http://www.w3.org/2001/XMLSchema#string

Tânia Varejão

http://www.w3.org/2001/XMLSchema#string

P304

29-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCEP.108.795906

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19808441

http://www.w3.org/2001/XMLSchema#string

P921